Abstract
AbstractOver recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g., products that capture physiological and behavioral metrics) in formal clinical research. Using 18 years of data from ClinicalTrials.gov, we document substantial growth in the use of connected digital products in clinical trials (~34% CAGR) and show that these products have been used across all phases of research and by a diverse group of trial sponsors. We identify four distinct use cases for how such connected products have been integrated within clinical trial design and suggest implications for various stakeholders engaging in clinical research.
Funder
Harvard-MIT Center for Regulatory Science
Publisher
Springer Science and Business Media LLC
Subject
Health Information Management,Health Informatics,Computer Science Applications,Medicine (miscellaneous)
Reference8 articles.
1. Coravos, A., Khozin, S. & Mandl, K. Developing and adopting safe and effective digital biomarkers to improve patient outcomes. npj Digital Med. 2, 14 (2019).
2. Bakker, J. P. et al. A systematic review of feasibility studies promoting the use of mobile technologies in clinical research. npj Digital Med. 2, 47 (2019).
3. Vegesna, A., Tran, M., Angelaccio, M. & Arcona, S. Remote patient monitoring via non-invasive digital technologies: a systematic review. Telemed. J. E Health 23, 3–17 (2017).
4. Noah, B. et al. Impact of remote patient monitoring on clinical outcomes: an updated meta-analysis of randomized controlled trials. npj Digital Med. 1, 20172 (2018).
5. Garg, S., Williams, N., Ip, A. & Dicker, A. Clinical integration of digital solutions in health care: an overview of the current landscape of digital technologies in cancer care. JCO Clin. Cancer Inform. 2, 2473–4276 (2018).
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献